Cervical lymph node response to 131I therapy in differentiated thyroid cancer using radiomics and clinical features - Top-Institutions - MDSpire

Cervical lymph node response to 131I therapy in differentiated thyroid cancer using radiomics and clinical features

  • By

  • Yi Ruan

  • Hui Yuan

  • Feng Zheng

  • Xuehua Chen

  • Cheng Xu

  • June 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Changde Hospital, Xiangya School of Medicine, Central South University
    Changde Hospital, Xiangya School of Medicine, Central South University

    Changde, Hunan

    Key Differentiators

    • Oncology

  • #2

    Karolinska University Hospital
    Karolinska University Hospital

    Stockholm, Sweden

    Key Differentiators

    • Oncology

  • #3

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Germany

    Key Differentiators

    • Oncology

Original Source(s)

Cervical lymph node response to 131I therapy in differentiated thyroid cancer using radiomics and clinical features

  • by Yi Ruan, Hui Yuan, Feng Zheng, Xuehua Chen, Cheng Xu

  • June 23, 2026

Related Content

Adjunctive photodynamic therapy improves outcomes and quality of life in condyloma acuminatum after radical cervical cancer surgery

Case Report: First report of PIK3CA-related overgrowth spectrum revealed by refractory chylorrhea after breast-conserving surgery: failed thoracic-duct ligation

Ultrasound-guided, nursing-led, phase-based swallowing rehabilitation in elderly patients with MIBG-positive medullary thyroid carcinoma following 131I-MIBG therapy